• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G150
Device Problems Off-Label Use (1494); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 08/19/2022
Event Type  Injury  
Manufacturer Narrative
The product has been received for analysis.Upon completion of the analysis of the complaint device, if there is any further relevant information from that review, a supplemental report will be filed.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) had an infection.A revision was performed and the crt-d with the right ventricular (rv) lead and right atrial (ra) lead were explanted.Additional information received indicates that there was no systemic infection and nothing was growing in the blood.This was just a pocket infection.A new device was implanted and the temporary lead removed.The old device will be returned to bsc.Furthermore, the patient has a pericardial effusion, but that this was an unrelated finding and was not caused by this procedure.No additional adverse patient effects were reported.
 
Manufacturer Narrative
The product has been received for analysis.Upon completion of the analysis of the complaint device, if there is any further relevant information from that review, a supplemental report will be filed.Correction to field b2: outcomes attributed to adverse event and f10: patient code.Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.Detailed analysis did not confirm allegation made with the device.Moreover, the baseline testing completed on the device found no failing conditions.All testing completed on the device passed or was not applicable, therefore no problem was detected.Furthermore, 'known inherent risk' conclusion code was based on the field report of infection or infection-related conditions.Infection is a known medical risk when the skin barrier is breached.Analysis of the returned product is not able to provide relevant information for infection-related allegations.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) had an infection.A revision was performed and the crt-d with the right ventricular (rv) lead and right atrial (ra) lead were explanted.Additional information received indicates that there was no systemic infection and nothing was growing in the blood.This was just a pocket infection.A new device was implanted and the temporary lead removed.The old device will be returned to bsc.Furthermore, the patient has a pericardial effusion, but that this was an unrelated finding and was not caused by this procedure.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key15354503
MDR Text Key299272246
Report Number2124215-2022-34154
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534614
UDI-Public00802526534614
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/05/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/23/2024
Device Model NumberG150
Device Catalogue NumberG150
Device Lot Number508002
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/30/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/05/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/03/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Life Threatening;
Patient Age73 YR
Patient SexFemale
-
-